Literature DB >> 12470247

Chemogenomics: bridging a drug discovery gap.

Konrad H Bleicher1.   

Abstract

With the successful completion of the human genome sequencing and the resulting plethora of genetic information now available novel technologies and applications have to be established to translate the huge amount of data generated into successful biological and biomedical research programs. The integration of various drug discovery disciplines within the parallel quest for novel targets and new molecular entities has meanwhile given rise to a quite popular term in pharmaceutical research named "chemogenomics". This review article gives an overview of the disciplines involved in this field and discusses the possible implications of this novel paradigm in drug discovery for the near future.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470247     DOI: 10.2174/0929867023368728

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  Toward automated biochemotype annotation for large compound libraries.

Authors:  Xian Chen; Yizeng Liang; Jun Xu
Journal:  Mol Divers       Date:  2006-09-12       Impact factor: 2.943

2.  Characterizing protein domain associations by Small-molecule ligand binding.

Authors:  Qingliang Li; Tiejun Cheng; Yanli Wang; Stephen H Bryant
Journal:  J Proteome Sci Comput Biol       Date:  2012-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.